Trial Outcomes & Findings for Clinical Validation for SpO2 Function of Masimo INVSENSOR00069 (NCT NCT06120777)

NCT ID: NCT06120777

Last Updated: 2024-11-27

Results Overview

The SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61. Arms= √(∑(i=1 to n) ((SpO2\_i-SaO2\_i )\^2 ))/n.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

89 participants

Primary outcome timeframe

1-3 hours

Results posted on

2024-11-27

Participant Flow

Participant milestones

Participant milestones
Measure
Masimo INVSENSOR00069
All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069. INVSENSOR00069: Noninvasive pulse oximeter
Overall Study
STARTED
89
Overall Study
COMPLETED
36
Overall Study
NOT COMPLETED
53

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Masimo INVSENSOR00069
n=36 Participants
All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069. INVSENSOR00069: Noninvasive pulse oximeter
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
Sex: Female, Male
Male
21 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
11 Participants
n=5 Participants
Race (NIH/OMB)
White
13 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
n=5 Participants
Region of Enrollment
United States
36 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1-3 hours

Population: 10 subjects not analyzed due to incorrect sensor 3 subjects not analyzed due to not desaturating to the lowest bin (70-80%)

The SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61. Arms= √(∑(i=1 to n) ((SpO2\_i-SaO2\_i )\^2 ))/n.

Outcome measures

Outcome measures
Measure
Masimo INVSENSOR00069
n=23 Participants
All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069. INVSENSOR00069: Noninvasive pulse oximeter
SpO2 Accuracy of Masimo INVSENSOR00069
1.72 % of oxygen saturated hemoglobin

Adverse Events

Masimo INVSENSOR00069

Serious events: 0 serious events
Other events: 9 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Masimo INVSENSOR00069
n=86 participants at risk
All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069. INVSENSOR00069: Noninvasive pulse oximeter
Nervous system disorders
Dizziness/Lightheadedness
5.8%
5/86 • 1-3 hours
Gastrointestinal disorders
Nausea
1.2%
1/86 • 1-3 hours
Cardiac disorders
Hypotension
1.2%
1/86 • 1-3 hours
Cardiac disorders
Increased heart rate
1.2%
1/86 • 1-3 hours
Nervous system disorders
Numbness
1.2%
1/86 • 1-3 hours

Additional Information

Ahmed Alghazi

Masimo Corporation

Phone: 949-297-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place